Research shows promising results for LHON gene therapy

August 05, 2020

Intravitreal injection offers safety, efficacy, and improved vision in patients

Tackling the challenge of noninfectious uveitis

August 05, 2020

Chronic cases can be difficult for retinal specialists, but treatment is satisfying.

Impact of baseline OCT on response to risuteganib for treatment of intermediate AMD (ASRS 2020)

August 04, 2020

Justic P. Ehlers, MD, speaks on the key findings and take-aways from his presentation "Impact of baseline OCT characteristics on response to risuteganib for the treatment of intermediate age-related macular degeneration (AMD)."

Thyroid eye disease: Not limited to visual impairment

August 04, 2020

Reduced quality of life, mental health issues are major adverse effects of TED

Beating burnout with camaraderie

August 03, 2020

For many physicians, "moral injury" may be an actual issue

Dexamethasone intracameral drug-delivery suspension in vitreoretinal surgery inflammation (ASRS 2020)

August 03, 2020

Daniel F. Kiernan, MD, FCS, speaks on the key findings and take-aways of his presentation "Dexamethasone intracameral drug-delivery suspension for inflammation associated with vitreoretinal surgery."

How one surgeon is integrating recent retina advances in COVID-19 (ASRS 2020)

August 02, 2020

S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon, and adapting to ever-changing operating room spacing and set-up in the COVID-19 environment

Diabetic retinopathy progression in anti-VEGF versus FA implant (ASRS 2020)

August 01, 2020

Caesar Luo, MD, shares the take-away points from his ASRS presentation, and how the topics from his talk may be applied day to day in retinal practice.

Undercutting severe COVID-19 with inhaled interferon beta

July 31, 2020

An inhaled formulation of interferon beta, significantly decreased the chances of hospitalized patients developing severe COVID-19 compared to placebo.

Themistocles: Everyone's second chance

July 31, 2020

Ancient election offers lesson to modern voters

AsclepiX lead candidate holds potential for wet AMD, DME, RVO (ASRS 2020)

July 31, 2020

Theresa Heah, MD, provides an update on AsclepiX’s AXT107, which is derived from a cryptic peptide within collagen IV that works by activating naturally existing, homeostatic mechanisms of angiogenesis.

Resident Writers Award Program - Vote Now

July 31, 2020

The Ophthalmology Times Resident Writers Award Program is a competitive writing program showcasing the best case studies in anterior segment.

Ocular trauma in the COVID-19 era

July 30, 2020

According to a study presented at the American Society of Ophthalmic Trauma conference, patients are experiencing domestic injuries, delaying care, traveling for care, and have less insurance.

Assessing the angle: Getting back to basics

July 30, 2020

How gonioscopy can offer ophthalmologists an option in treating patients with glaucoma

Pass-through provides vehicle to drive innovation

July 30, 2020

As more novel ophthalmic drugs and devices become available under the CMS “pass-through”designation, practices should be proactive in embracing these products.

Alcon showcases latest retina innovations, data (ASRS 2020)

July 30, 2020

ASRS 2020: Josh Anderson speaks on the highlights from Alcon, including new data on the performance benefits of the Hypervit dual blade 20,000 cpm probe and the launch of the NGENUITY 1.4 upgrade.

What Aviceda’s lead candidate AVD-104 may mean for dry AMD (ASRS 2020)

July 30, 2020

Derek Kunimoto, MD, JD, focuses on Aviceda's technology, which will aim to target various immune system responses that contribute to pathology associated with dry AMD.

COVID-19: HHS extends public health emergency declaration

July 29, 2020

The Department of Health and Human Services recently extended the national public health emergency declared for the COVID-19 pandemic, thereby extending payment and regulatory flexibilities. Amid the pandemic, ophthalmologists continue to adapt to practicing in the era of COVID-19.

Evaluating 3-year-recurrence rate in non-infectious posterior segment veitis post-FAi

July 29, 2020

Dilraj Grewal, MD, associate professor of ophthalmology at Duke Eye Center/ director of grading at the Duke Reading Center, speaks on his presentation "Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis Following an Injectable Fluocinolone Acetonide Insert," during the virtual 2020 ASRS meeting.

Developing a new therapy: Where do we go from here?

July 29, 2020

Researchers must weigh emotional, financial, and reputational considerations